Cargando…

The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis

BACKGROUND: Metabolic syndrome (MS) is a collection of metabolic disorders which leads to early cardiovascular disease and diabetes type II. Regarding the wide range of its prevalence in Iran, this systematic review and meta-analysis determined the overall prevalence of the metabolic syndrome in Ira...

Descripción completa

Detalles Bibliográficos
Autores principales: MAZLOOMZADEH, Saeideh, RASHIDI KHAZAGHI, Zahra, MOUSAVINASAB, Nouraddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996331/
https://www.ncbi.nlm.nih.gov/pubmed/29900131
_version_ 1783330831224274944
author MAZLOOMZADEH, Saeideh
RASHIDI KHAZAGHI, Zahra
MOUSAVINASAB, Nouraddin
author_facet MAZLOOMZADEH, Saeideh
RASHIDI KHAZAGHI, Zahra
MOUSAVINASAB, Nouraddin
author_sort MAZLOOMZADEH, Saeideh
collection PubMed
description BACKGROUND: Metabolic syndrome (MS) is a collection of metabolic disorders which leads to early cardiovascular disease and diabetes type II. Regarding the wide range of its prevalence in Iran, this systematic review and meta-analysis determined the overall prevalence of the metabolic syndrome in Iran. METHODS: In this systematic review and meta-analysis, the Medline, ISI, IranMedex, and SID were searched using “metabolic syndrome”, “syndrome X”, “prevalence”, and “Iran” keywords from 2002 to 2012. A total of 223 articles were found in which 14 studies were considered for meta-analysis. Data were analyzed using fixed and random model and meta-regression in STATA. RESULTS: The prevalence of MS for those who were 20 yr and older was 23.8% (95%CI: 18.99–28.67) and in under 20 was 10.98% (95%CI: 7.75–14.2). Metabolic syndrome was more frequent in women (25.5%) than in men (17.16%) and was increased with increasing age. The most frequent component of metabolic syndrome was low HDL cholesterol (59.7%) followed by hypertriglyceridemia (39.5%). CONCLUSION: Regarding a high prevalence of metabolic syndrome and some of its components such as low HDL and high triglyceride in our country, implementation of programs for metabolic syndrome prevention is necessary.
format Online
Article
Text
id pubmed-5996331
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-59963312018-06-13 The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis MAZLOOMZADEH, Saeideh RASHIDI KHAZAGHI, Zahra MOUSAVINASAB, Nouraddin Iran J Public Health Review Article BACKGROUND: Metabolic syndrome (MS) is a collection of metabolic disorders which leads to early cardiovascular disease and diabetes type II. Regarding the wide range of its prevalence in Iran, this systematic review and meta-analysis determined the overall prevalence of the metabolic syndrome in Iran. METHODS: In this systematic review and meta-analysis, the Medline, ISI, IranMedex, and SID were searched using “metabolic syndrome”, “syndrome X”, “prevalence”, and “Iran” keywords from 2002 to 2012. A total of 223 articles were found in which 14 studies were considered for meta-analysis. Data were analyzed using fixed and random model and meta-regression in STATA. RESULTS: The prevalence of MS for those who were 20 yr and older was 23.8% (95%CI: 18.99–28.67) and in under 20 was 10.98% (95%CI: 7.75–14.2). Metabolic syndrome was more frequent in women (25.5%) than in men (17.16%) and was increased with increasing age. The most frequent component of metabolic syndrome was low HDL cholesterol (59.7%) followed by hypertriglyceridemia (39.5%). CONCLUSION: Regarding a high prevalence of metabolic syndrome and some of its components such as low HDL and high triglyceride in our country, implementation of programs for metabolic syndrome prevention is necessary. Tehran University of Medical Sciences 2018-04 /pmc/articles/PMC5996331/ /pubmed/29900131 Text en Copyright© Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
MAZLOOMZADEH, Saeideh
RASHIDI KHAZAGHI, Zahra
MOUSAVINASAB, Nouraddin
The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis
title The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis
title_full The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis
title_fullStr The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis
title_full_unstemmed The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis
title_short The Prevalence of Metabolic Syndrome in Iran: A Systematic Review and Meta-analysis
title_sort prevalence of metabolic syndrome in iran: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996331/
https://www.ncbi.nlm.nih.gov/pubmed/29900131
work_keys_str_mv AT mazloomzadehsaeideh theprevalenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis
AT rashidikhazaghizahra theprevalenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis
AT mousavinasabnouraddin theprevalenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis
AT mazloomzadehsaeideh prevalenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis
AT rashidikhazaghizahra prevalenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis
AT mousavinasabnouraddin prevalenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis